𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The Biology of Chronic Myelogenous Leukemia: Implications for Imatinib Therapy

✍ Scribed by Ricardo H. Alvarez; Hagop Kantarjian; Jorge E. Cortes

Book ID
117821998
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
902 KB
Volume
44
Category
Article
ISSN
1532-8686

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Significance of myelofibrosis in early c
Significance of myelofibrosis in early chronic-phase, chronic myelogenous leukemia on imatinib mesylate therapy
✍ Hagop M. Kantarjian; Carlos E. Bueso-Ramos; Moshe Talpaz; Susan O'Brien; Francis πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 98 KB πŸ‘ 2 views

## Abstract ## BACKGROUND Myelofibrosis is associated historically with a poor prognosis in patients with chronic myelogenous leukemia (CML). Its significance in the recent era of effective therapy with imatinib mesylate is unknown. ## METHODS The current study evaluated the significance of the